In the news | 29th June 2023
Overcoming the BioPharma paradox of advanced science and slow digital transformation
The BioPharma industry faces a paradox: while scientific innovation accelerates, digital transformation lags. Breaking this paradox requires a commitment to digital transformation, unlocking the industry’s potential for accelerating drug development and advancing human health.
Pietro Forgione, General Manager at IDBS, explores the paradox that the BioPharma industry is facing. Learn how advances in digital technology and the tailwinds of external forces offer the pharma industry a chance to break out of this paradox.
Read the article in PharmaTimes Magazine.
Tradeshow | Festival of Biologics | October 2023
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Tradeshow | Biologics Contract Manufacturing Asia | September, 2023
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!
Digitize pharma lifecycle management for faster regulatory filing
Robust digital workflows in pharma lifecycle management can reduce errors and time to compile data, speeding up regulatory filing.
Is it really an ELN you need?
Thinking of upgrading from a standard ELN? Discover the benefits of centralized BioPharma Lifecycle Management platforms compared to standard ELNs.